A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: A 3 month, randomised study

British Journal of Ophthalmology

Volumn 84, Issue 6, 2000, Pages 579-582

  O'Donoghue, E P ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; LEVOBUNOLOL; PILOCARPINE; TIMOLOL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLEPHARITIS; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA OPACITY; DERMATITIS; DRUG EFFICACY; DRUG TOLERABILITY; EPIPHORA; EYE DISEASE; FACE EDEMA; FEMALE; GLAUCOMA; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RETINA HEMORRHAGE; STATISTICAL ANALYSIS; TASTE DISORDER; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSTAGLANDINS F, SYNTHETIC; SULFONAMIDES; THIOPHENES;

EID: 0034046563     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.6.579     Document Type: Article

References (9)

1. Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343-50.
2. Maus TL, Larsson L-I, McLaren JW, et al. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:45-9.
3. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 1995; 102:1743-52.
4. Watson P, Stjernschantz J, the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996;103:126-37.
5. Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103:138-47.
6. 2α analogue. Adv Prostaglandin Thromboxane Leukot Res 1995; 23:513-8.
7. 2α, analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297-304.
8. Strahlman E, Tipping R, Vogel R, et al. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995;113: 1009-16.
9. Wayman L, Larsson L-I, Maus T, et al. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:1368-71.